https://www.eipg.eu/about/2021-08-06T09:26:19+00:00https://www.eipg.eu/presentations/2024-09-24T07:16:41+00:00https://www.eipg.eu/news-from-eipg/2024-09-24T07:17:26+00:00https://www.eipg.eu/position-papers/2024-09-24T07:18:18+00:00https://www.eipg.eu/guides-and-codes/2024-09-24T07:13:08+00:00https://www.eipg.eu/education/2024-09-24T07:15:57+00:00https://www.eipg.eu/members-area/2024-09-24T07:18:56+00:00https://www.eipg.eu/eipg-code-of-practice-for-qualified-persons-2020/2024-09-24T07:19:36+00:00https://www.eipg.eu/5th-december-2019/2021-03-11T12:55:47+00:00https://www.eipg.eu/the-role-of-the-body-clock-in-drug-development-efficacy-and-toxicity-webinar/2024-09-24T07:20:03+00:00https://www.eipg.eu/consultation-on-annex-21-importation-of-medicinal-products-of-the-eudralex-volume-4-webinar/2024-09-24T07:21:46+00:00https://www.eipg.eu/eipg-publishes-updated-version-of-code-of-practice-for-qualified-persons/2024-09-24T07:09:40+00:00https://www.eipg.eu/how-a-pandemic-has-affected-the-pharma-industry-webinar/2024-09-24T07:11:54+00:00https://www.eipg.eu/annex-1-a-focus-on-its-main-issues-webinar/2024-09-24T07:22:34+00:00https://www.eipg.eu/the-practical-implementation-of-eu-regulations-for-medical-devices-and-in-vitro-diagnostic-medical-devices-webinar/2024-09-24T07:22:20+00:00https://www.eipg.eu/the-importance-of-knowledge-management-in-both-the-development-and-manufacture-of-medicinal-products-webinar/2021-05-05T10:29:07+00:00https://www.eipg.eu/eipg-virtual-symposium-the-post-covid-era-and-pharmacy/2021-06-07T07:16:03+00:00https://www.eipg.eu/virtual-symposium-the-post-covid-era-and-pharmacy/2021-07-02T12:41:00+00:00https://www.eipg.eu/ema-publishes-qa-document-about-parallel-distribution/2021-07-09T12:28:00+00:00https://www.eipg.eu/small-scale-models-for-process-development/2021-07-16T00:00:00+00:00https://www.eipg.eu/the-new-vision-for-the-european-research-landscape/2021-07-23T10:07:12+00:00https://www.eipg.eu/the-new-pics-guideline-on-data-integrity/2021-07-30T10:50:00+00:00https://www.eipg.eu/the-new-swiss-national-ehealth-infrastructure/2021-08-06T10:59:00+00:00https://www.eipg.eu/draft-guidelines-open-for-consultation/2021-08-13T08:08:28+00:00https://www.eipg.eu/artificial-intelligence-in-medicine-regulation/2021-08-20T10:59:00+00:00https://www.eipg.eu/pbpk-modelling-and-simulation/2021-08-27T22:57:00+00:00https://www.eipg.eu/a-new-life-science-vision-to-inspire-the-future-of-uk-pharma-and-biotech-sector/2021-09-03T18:03:21+00:00https://www.eipg.eu/the-opportunity-for-repurposing-of-oncology-medicines/2021-09-10T21:49:00+00:00https://www.eipg.eu/the-pact-for-research-and-innovation-in-europe/2021-09-17T10:59:00+00:00https://www.eipg.eu/medical-cannabis-in-europe/2021-09-24T09:59:00+00:00https://www.eipg.eu/the-new-guideline-on-combination-products-between-medicinesand-medical-devices/2021-10-01T09:10:00+00:00https://www.eipg.eu/ich-q13-guideline-on-continuous-manufacturing/2021-10-08T17:06:34+00:00https://www.eipg.eu/consultation-on-the-reform-of-the-european-pharmaceutical-legislation/2021-10-15T14:09:04+00:00https://www.eipg.eu/first-steps-of-the-hera-authority-and-comments-from-stakeholders/2021-10-22T18:14:56+00:00https://www.eipg.eu/automation-of-aseptic-manufacturing/2021-10-29T15:48:47+00:00https://www.eipg.eu/imp-manufacturing-in-the-era-of-the-clinical-trial-regulation/2021-11-02T17:26:11+00:00https://www.eipg.eu/a-step-forward-towards-the-african-medicines-agency/2021-11-05T11:21:35+00:00https://www.eipg.eu/a-new-role-for-ema-and-a-pilot-project-for-the-repurposing-of-medicines/2021-11-12T19:41:49+00:00https://www.eipg.eu/commission-establishes-portfolio-of-10-most-promising-treatmentsfor-covid-19/2021-11-19T13:39:39+00:00https://www.eipg.eu/steps-forward-towards-the-new-framework-for-hta/2021-11-26T19:06:17+00:00https://www.eipg.eu/consultation-on-the-reform-of-the-european-pharmaceutical-legislation-2/2021-11-27T14:45:00+00:00https://www.eipg.eu/greatest-common-divisor-for-product-traceability-and-batch-definition-in-continuous-biomanufacturing/2021-12-03T16:16:54+00:00https://www.eipg.eu/steps-towards-the-final-approval-of-the-ip-action-plan/2021-12-10T18:53:30+00:00https://www.eipg.eu/horizon-europe-association-joint-statement/2021-12-10T20:34:22+00:00https://www.eipg.eu/emas-oms-has-turned-mandatory-for-centrally-authorised-products/2021-12-17T20:10:00+00:00https://www.eipg.eu/season-greetings-2022/2021-12-21T20:43:01+00:00https://www.eipg.eu/a-study-on-medicines-shortages-from-the-european-commission/2021-12-24T10:54:00+00:00https://www.eipg.eu/webinar-antimicrobial-resistance/2021-12-31T17:44:00+00:00https://www.eipg.eu/guidilene-on-the-acceptability-of-names-for-human-medicines/2022-01-07T22:36:00+00:00https://www.eipg.eu/emas-qas-on-the-integration-of-eudragmdp-and-oms/2022-01-14T10:27:45+00:00https://www.eipg.eu/icrma-published-a-reflection-paper-on-remote-inspections/2022-01-21T18:48:45+00:00https://www.eipg.eu/the-european-medicines-regulatory-network-data-standardisation-strategy/2022-01-28T16:39:25+00:00https://www.eipg.eu/act-eu-the-eus-vision-for-the-future-of-clinical-trials/2022-02-04T08:41:00+00:00https://www.eipg.eu/investing-in-early-formulation-as-success-factor/2022-02-11T20:16:59+00:00https://www.eipg.eu/a-record-year-for-biotech-investments-in-uk-a-year-after-the-brexit/2022-02-18T22:17:24+00:00https://www.eipg.eu/revision-of-the-cdmh-qa-document-on-nitrosamine-impurities/2022-02-25T16:44:21+00:00https://www.eipg.eu/continuous-manufacturing-of-pharmaceuticals-higher-quality-greater-flexibility/2022-03-01T17:03:37+00:00https://www.eipg.eu/the-faculty-of-pharmacy-in-brno-is-once-again-a-part-of-masaryk-university/2022-02-28T15:54:00+00:00https://www.eipg.eu/the-main-contributions-to-the-consultation-on-the-revision-of-the-pharmaceutical-legislation/2022-03-04T17:46:58+00:00https://www.eipg.eu/the-new-annex-21-to-the-gmps/2022-03-11T10:53:57+00:00https://www.eipg.eu/the-made-in-europe-partnership-for-manufacturing/2022-03-18T19:28:54+00:00https://www.eipg.eu/fat-and-sat-testing-a-critical-step-for-the-introduction-of-new-equipment/2022-03-25T15:43:20+00:00https://www.eipg.eu/academic-research-in-industrial-pharmacy-field/2022-03-29T21:28:03+00:00https://www.eipg.eu/revision-of-the-pics-gmp-guide-annex-13-and-annex-16/2022-04-01T17:03:08+00:00https://www.eipg.eu/edqm-the-rtemis-scheme-for-remote-inspections-and-newapplication-forms-for-ceps/2022-04-09T07:18:33+00:00https://www.eipg.eu/trends-in-the-development-of-new-dosage-forms/2022-04-16T14:30:00+00:00https://www.eipg.eu/ipi-a-new-international-procurement-instrument-at-the-eu-level/2022-04-22T12:04:34+00:00https://www.eipg.eu/a-new-joint-work-plan-to-2023-for-ema-and-eunethta21/2022-04-29T10:57:00+00:00https://www.eipg.eu/key-issues-in-technical-due-diligences/2022-05-06T16:19:00+00:00https://www.eipg.eu/joint-implementation-plan-for-the-ivdr-regulation/2022-05-13T17:01:51+00:00https://www.eipg.eu/pics-annual-report-2021/2022-05-20T14:28:00+00:00https://www.eipg.eu/draft-topics-for-the-first-ihi-calls-for-proposals/2022-05-27T19:23:09+00:00https://www.eipg.eu/implications-and-opportunities-of-ichq2-and-ichq14/2022-06-03T10:25:42+00:00https://www.eipg.eu/emas-consultation-on-draft-qandas-on-remote-certification-of-batches-by-qp/2022-06-03T16:44:00+00:00https://www.eipg.eu/ivdr-in-force-new-mdcg-guidelines-and-criticalities-for-innovation-in-diagnostics/2022-06-10T17:00:02+00:00https://www.eipg.eu/the-transition-towards-ema-new-digital-application-dataset-integration-dadi/2022-06-17T18:18:42+00:00https://www.eipg.eu/data-governance-act-and-emas-consultation-on-the-ctis/2022-06-24T18:19:02+00:00https://www.eipg.eu/challenges-for-the-eic-governance-and-opportunities-for-innovation/2022-07-01T19:26:57+00:00https://www.eipg.eu/current-inspection-trends-and-new-approaches-to-the-monitoring-of-post-inspection-activities/2022-07-08T19:00:21+00:00https://www.eipg.eu/emas-industry-stakeholders-group-isg/2022-07-15T18:36:01+00:00https://www.eipg.eu/icmra-two-pilot-programmes-to-optimise-regulatory-assessment-and-inspections/2022-07-22T19:37:46+00:00https://www.eipg.eu/the-new-european-innovation-agenda/2022-07-29T10:08:00+00:00https://www.eipg.eu/trends-in-drug-delivery-and-formulation/2022-08-05T11:15:16+00:00https://www.eipg.eu/efpia-annual-report-on-the-pharmaceutical-industry-2022/2022-09-09T10:56:00+00:00https://www.eipg.eu/webinar-contamination-control-strategy-an-implementation-roadmap/2022-09-07T18:47:00+00:00https://www.eipg.eu/act-eu-workplan-2022-2026/2022-09-15T23:11:00+00:00https://www.eipg.eu/webinar-implementation-of-contamination-control-strategy-using-the-eca-template/2022-09-28T18:24:27+00:00https://www.eipg.eu/real-world-evidence-for-regulatory-decision-making/2022-09-23T19:22:00+00:00https://www.eipg.eu/patient-involvement-in-the-development-regulation-and-safeuse-of-medicines/2022-09-30T20:01:06+00:00https://www.eipg.eu/how-to-approach-drug-substance-supply-in-new-product-introduction-processes/2022-10-07T11:21:00+00:00https://www.eipg.eu/mdcg-a-position-paper-on-the-capacity-of-notified-bodies/2022-10-14T16:50:00+00:00https://www.eipg.eu/the-current-status-of-trade-agreements/2022-10-21T19:53:00+00:00https://www.eipg.eu/the-fda-warns-about-the-manufacture-of-medicinal-and-non-pharmaceutical-products-on-the-same-equipment/2022-11-04T21:38:00+00:00https://www.eipg.eu/webinar-the-impact-of-pharmaceuticals-on-the-environment/2025-09-22T07:10:49+00:00https://www.eipg.eu/general-assembly-2022-bureau-elections/2022-10-24T21:57:00+00:00https://www.eipg.eu/what-happens-after-ip-loss-of-protection/2022-11-11T20:41:00+00:00https://www.eipg.eu/a-concept-paper-on-the-revision-of-annex11/2022-11-17T23:17:00+00:00https://www.eipg.eu/comments-to-the-draft-ich-q2-r2-and-ich-q14-guidelines/2022-11-25T21:14:00+00:00https://www.eipg.eu/new-steps-towards-the-activation-of-the-unified-patent-court/2022-12-01T23:01:00+00:00https://www.eipg.eu/icmra-report-on-best-practices-against-antimicrobial-resistance/2022-12-09T01:15:00+00:00https://www.eipg.eu/emas-new-quality-innovation-expert-group-qig/2022-12-16T02:22:00+00:00https://www.eipg.eu/european-council-conclusions-on-the-european-innovation-agenda-and-research-infrastructures/2023-01-06T02:43:00+00:00https://www.eipg.eu/some-perspectives-on-green-pharmaceuticals/2023-01-20T19:00:00+00:00https://www.eipg.eu/edqm-introduces-a-consultation-phase-in-the-management-of-cep-documents/2023-01-26T23:32:00+00:00https://www.eipg.eu/review-of-the-pharmaceutical-legislation-the-proposals-of-the-industrial-associations/2023-02-10T15:06:00+00:00https://www.eipg.eu/human-dietary-exposure-to-residues-of-veterinary-medicines/2023-02-16T23:00:00+00:00https://www.eipg.eu/hera-reports-on-stockpiling-of-antimicrobials/2023-02-24T00:29:00+00:00https://www.eipg.eu/the-windsor-framework/2023-03-03T03:43:00+00:00https://www.eipg.eu/draft-ich-m13a-guideline-on-bioequivalence-open-for-consultation/2023-03-17T08:47:42+00:00https://www.eipg.eu/webinar-ich-q12-product-lifecycle-management/2023-03-24T21:25:00+00:00https://www.eipg.eu/ecas-guide-to-compliant-equipment-design/2023-03-31T06:38:36+00:00https://www.eipg.eu/how-to-prepare-to-the-entry-into-force-of-cep-20/2023-04-07T10:45:30+00:00https://www.eipg.eu/pics-guidance-for-gdp-inspectors-published/2023-04-17T08:42:34+00:00https://www.eipg.eu/trends-for-the-future-of-the-pharmaceutical-manufacturing/2023-04-21T10:19:05+00:00https://www.eipg.eu/the-eu-commission-proposal-of-the-new-pharmaceutical-legislation/2023-05-05T11:42:45+00:00https://www.eipg.eu/pioneer-plan-uks-alternative-to-support-research-and-innovation/2023-04-28T08:27:00+00:00https://www.eipg.eu/the-proposals-of-the-eu-commission-for-the-revision-of-the-ip-legislation/2023-05-12T09:03:16+00:00https://www.eipg.eu/webinar-pharmacovigilance-and-the-role-of-prac/2023-05-08T18:13:00+00:00https://www.eipg.eu/ema-new-features-for-the-prime-scheme/2023-05-19T11:24:00+00:00https://www.eipg.eu/the-new-mhra-framework-for-clinical-studies/2023-05-26T20:22:00+00:00https://www.eipg.eu/ema-recommendations-to-prevent-medicines-shortages/2023-06-08T23:06:00+00:00https://www.eipg.eu/the-interface-between-pharmaceutical-products-and-medical-devices/2023-06-02T18:37:00+00:00https://www.eipg.eu/the-debate-on-the-do-no-significant-harm-principle-in-randd/2023-06-30T05:40:00+00:00https://www.eipg.eu/ema-three-year-work-plan-for-the-quality-domain/2023-07-07T19:42:00+00:00https://www.eipg.eu/ema-reflection-paper-on-single-arm-clinical-trials/2023-07-14T05:37:00+00:00https://www.eipg.eu/eipg-general-assembly-and-elections-2023/2023-09-13T08:29:00+00:00https://www.eipg.eu/the-new-pharmaceutical-legislation-seminar-at-eu-parliament/2023-09-15T09:49:51+00:00https://www.eipg.eu/uk-will-participate-to-european-research-programmes/2023-09-29T09:27:33+00:00https://www.eipg.eu/ema-reflection-paper-on-ai-in-the-pharmaceutical-lifecycle/2023-09-22T10:03:25+00:00https://www.eipg.eu/insights-to-the-industrial-pharmacist-role-for-the-future/2023-09-25T19:42:00+00:00https://www.eipg.eu/eu-industrial-forum-report-on-the-future-of-advanced-manufacturing-technologies/2023-10-06T09:52:14+00:00https://www.eipg.eu/the-hearings-at-the-envi-committee-on-the-revision-of-pharmaceutical-legislation/2023-10-13T19:51:01+00:00https://www.eipg.eu/webinar-building-a-healthier-and-more-environmentally-sustainable-future/2025-09-22T07:10:41+00:00https://www.eipg.eu/the-uks-statutory-scheme-revision-for-branded-medicines/2023-10-20T18:37:00+00:00https://www.eipg.eu/ec-communication-how-to-address-critical-medicines-shortages-part-1/2023-10-27T20:02:00+00:00https://www.eipg.eu/ec-communication-part-2-an-alliance-to-support-eu-pharma-supply-chain/2023-11-03T15:29:00+00:00https://www.eipg.eu/reactions-to-the-proposed-ban-of-pfas/2023-11-10T21:46:00+00:00https://www.eipg.eu/eps-draft-position-on-unitary-spc-and-spc-regulation-revision/2023-11-17T20:31:00+00:00https://www.eipg.eu/the-drug-shortage-situation-eipg-point-of-view/2023-11-24T09:08:34+00:00https://www.eipg.eu/the-risk-of-a-biosimilar-void-in-europe/2023-12-01T13:40:07+00:00https://www.eipg.eu/the-current-status-of-the-transition-to-the-mdr-and-ivdr-regulations/2023-12-08T08:39:22+00:00https://www.eipg.eu/swissmedics-technical-interpretation-of-annex-1/2023-12-15T16:25:00+00:00https://www.eipg.eu/the-first-union-list-of-critical-medicines/2023-12-21T13:36:35+00:00https://www.eipg.eu/the-icmra-collaborative-hybrid-inspection-pilot-chip/2024-01-22T17:35:00+00:00https://www.eipg.eu/training-course-annex-1/2024-01-29T14:16:07+00:00https://www.eipg.eu/european-council-recommendations-on-r-and-i/2024-02-05T12:24:00+00:00https://www.eipg.eu/webinar-oral-colon-drug-delivery-design-strategies/2024-02-05T13:02:52+00:00https://www.eipg.eu/approvals-and-flops-in-drug-development-in-2023/2024-02-12T08:54:30+00:00https://www.eipg.eu/the-final-report-on-horizon-2020-and-the-transition-to-fp10/2024-02-19T12:22:00+00:00https://www.eipg.eu/emas-pilot-scheme-for-academic-and-non-profit-development-of-atmps/2024-02-26T15:24:46+00:00https://www.eipg.eu/the-pgeu-annual-medicine-shortages-report/2024-03-04T13:55:08+00:00https://www.eipg.eu/generative-ai-in-drug-development/2024-03-11T13:03:50+00:00https://www.eipg.eu/environmental-sustainability-the-eipg-perspective/2025-09-22T07:11:52+00:00https://www.eipg.eu/how-ai-is-changing-the-pharma-industry-and-the-industrial-pharmacists-role/2024-03-18T09:52:07+00:00https://www.eipg.eu/reform-of-pharma-legislation-the-debate-on-regulatory-data-protection/2024-04-01T20:19:54+00:00https://www.eipg.eu/the-eu-parliament-voted-its-position-on-the-unitary-spc/2024-04-08T21:33:37+00:00https://www.eipg.eu/new-member-within-eipg/2024-04-22T21:21:02+00:00https://www.eipg.eu/general-assembly-2024/2024-07-03T13:39:39+00:00https://www.eipg.eu/a-study-on-the-reprocessing-and-reusing-of-single-use-devices/2024-07-29T11:31:42+00:00https://www.eipg.eu/the-new-european-supply-chain-law-and-a-transatlantic-partnership/2024-09-06T16:57:13+00:00https://www.eipg.eu/whats-going-on-for-the-future-of-rd-programmes/2024-10-15T21:55:36+00:00https://www.eipg.eu/mario-draghis-report-a-focus-on-the-proposed-actions-for-the-pharma-sector/2024-10-15T21:55:02+00:00https://www.eipg.eu/eipg-participates-in-the-emas-quality-innovation-group/2024-10-15T20:41:54+00:00https://www.eipg.eu/accelerating-clinical-trials-in-the-european-union-act-eu/2024-10-15T21:52:57+00:00https://www.eipg.eu/eipg-webinar-pharmacist-5-0/2024-10-16T00:10:58+00:00https://www.eipg.eu/consultation-on-the-revision-of-the-guideline-on-the-chemistry-of-active-substances/2025-03-25T18:13:34+00:00https://www.eipg.eu/the-first-revision-of-the-era-guideline-on-environmental-risk-assessment/2025-09-22T07:10:18+00:00https://www.eipg.eu/pharmaceutical-technology-transfers-an-evolving-landscape-towards-the-improvement-of-globalhealth/2024-11-18T20:48:39+00:00https://www.eipg.eu/academic-patenting-on-the-rise/2024-11-30T21:29:43+00:00https://www.eipg.eu/highlights-from-the-hearings-of-the-new-eu-commissioners/2024-12-31T20:17:41+00:00https://www.eipg.eu/the-new-european-shortages-monitoring-platform-becomes-mandatory/2025-05-05T12:51:04+00:00https://www.eipg.eu/ich-e6r3-a-new-era-for-good-clinical-practice-in-industrial-pharmacy/2025-05-05T12:51:31+00:00https://www.eipg.eu/pic-s-new-guidances-on-remote-and-hybrid-inspections/2025-05-05T12:51:43+00:00https://www.eipg.eu/the-eu-ai-act-compliance-obligations-and-business-opportunities-in-2025/2025-05-05T12:51:55+00:00https://www.eipg.eu/the-eus-competitiveness-compass-and-the-new-eu-biotech-hub/2025-05-05T12:52:07+00:00https://www.eipg.eu/the-fdas-advanced-manufacturing-technologies-designation-program/2025-05-05T12:52:16+00:00https://www.eipg.eu/the-clean-industrial-deal-and-the-omnibus-package-on-simplification/2025-03-25T18:07:26+00:00https://www.eipg.eu/eipg-webinar-the-cumulative-impact-of-environment-and-chemical-legislation-and-the-future-of-the-healthcare-sector/2025-09-22T07:11:39+00:00https://www.eipg.eu/the-proposal-of-a-critical-medicines-act/2025-04-04T15:18:51+00:00https://www.eipg.eu/ema-guideline-on-investigational-atmps/2025-05-05T12:50:06+00:00https://www.eipg.eu/in-memory-of-john-jolley/2025-04-24T13:46:05+00:00https://www.eipg.eu/eipg-elects-new-bureau-at-general-assembly-in-madrid-anni-svala-elected-president/2025-05-19T07:51:13+00:00https://www.eipg.eu/new-approach-methodologies-the-emas-horizon-scanning-report/2025-05-19T08:01:11+00:00https://www.eipg.eu/current-status-and-perspectives-in-joint-clinical-assessment/2025-05-19T08:40:55+00:00https://www.eipg.eu/eu-life-sciences-strategy-comments-to-the-call-for-evidence/2025-06-04T16:13:29+00:00https://www.eipg.eu/steps-towards-the-new-pharma-package-and-the-eu-startup-and-scaleup-strategy/2025-06-30T15:48:12+00:00https://www.eipg.eu/latest-emas-updates-on-the-use-of-rwe-in-regulatory-decision-making/2025-07-25T15:10:34+00:00https://www.eipg.eu/the-eu-commissions-study-on-the-deployment-of-ai-in-healthcare/2025-09-11T13:03:21+00:00https://www.eipg.eu/pharmaceuticals-in-the-environment-the-final-report-of-the-ad-hoc-working-group/2025-09-22T07:08:25+00:00https://www.eipg.eu/consultation-open-on-the-revision-of-gmps-chapter-1/2025-09-29T07:17:54+00:00https://www.eipg.eu/piero-iamartino-appointed-as-executive-director-of-the-eipg/2025-10-01T08:41:36+00:00https://www.eipg.eu/the-challenging-roadmap-to-design-the-future-of-eus-rd/2025-10-13T08:14:30+00:00https://www.eipg.eu/the-uks-new-decentralised-manufacturing-framework/2025-11-06T13:43:10+00:00https://www.eipg.eu/the-eu-commission-adopted-the-rules-for-jcas-of-medical-devices-and-in-vitro-diagnostics/2025-11-25T13:18:01+00:00https://www.eipg.eu/bacteriophages-and-amr-the-beginning-of-a-new-era/2025-12-10T15:42:16+00:00https://www.eipg.eu/many-advancements-in-the-setting-up-of-the-new-pharmaceutical-legislation/2026-01-26T11:23:16+00:00https://www.eipg.eu/2026-trends-in-pharmaceutical-development/2026-02-13T10:05:17+00:00https://www.eipg.eu/idap-the-ifpmas-vision-of-innovation-development-and-access-pathways/2026-02-27T16:57:35+00:00https://www.eipg.eu/tabletting-technology-course-2026-royal-pharmaceutical-society/2026-03-06T08:41:35+00:00https://www.eipg.eu/act-eu-multi-stakeholder-platform-annual-meeting-2025/2026-03-09T17:24:46+00:00https://www.eipg.eu/the-first-report-on-the-implementation-of-the-hta-regulation/2026-03-23T09:36:59+00:00https://www.eipg.eu/the-current-status-of-digital-health-technologies-in-the-eu/2026-04-29T06:56:29+00:00https://www.eipg.eu/65th-afi-symposium-2026-the-healthcare-industry-in-the-age-of-artificial-intelligence/2026-05-14T09:23:47+00:00